DRUG-PATHWAY

DRUGs and PATHWAYs

PATHWAY_NAME	REACTOME_ID	KEGG_ID	DRUG_NAME	PUBCHEM_CID	Datasource
Neuroactive ligand-receptor interaction	R-HSA-5632681	map04080	Prestwick-967	None	drug-path
Olfactory transduction	R-HSA-9751605	map04740	Prestwick-967	None	drug-path
Non-homologous end-joining	R-HSA-5693571	map03450	Prestwick-967	None	drug-path
MAPK signaling pathway	R-HSA-9652817	map04010	Prestwick-967	None	drug-path
RNA polymerase	R-HSA-73864	map03020	Prestwick-967	None	drug-path
Renal cell carcinoma	R-HSA-9794523	map05211	letrozole	3902	drug-path
Pathways in cancer	R-HSA-9824443	map05200	letrozole	3902	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	letrozole	3902	drug-path
Pancreatic cancer	R-HSA-9700206	map05212	letrozole	3902	drug-path
Cell cycle	R-HSA-1640170	map04110	letrozole	3902	drug-path
Prostate cancer	R-HSA-2990872	map05215	letrozole	3902	drug-path
Bladder cancer	R-HSA-9700206	map05219	letrozole	3902	drug-path
Thyroid cancer	R-HSA-9700206	map05216	letrozole	3902	drug-path
p53 signaling pathway	R-HSA-168638	map04115	letrozole	3902	drug-path
TGF-beta signaling pathway	R-HSA-168638	map04350	letrozole	3902	drug-path
Endometrial cancer	R-HSA-2077421	map05213	letrozole	3902	drug-path
Chronic myeloid leukemia	R-HSA-9680350	map05220	letrozole	3902	drug-path
Ribosome	R-HSA-5368277	map03010	letrozole	3902	drug-path
RNA polymerase	R-HSA-73864	map03020	letrozole	3902	drug-path
Renal cell carcinoma	R-HSA-9794523	map05211	gibberellic acid	92766	drug-path